 |
인쇄하기
취소
|
Two drugmakers win medication redemption lawsuit against goverment
The Seoul Central District Court ruled on October 14 that Yungin Pharm and Ildong Pharm should not refund their revenues associated with bioequivalence fabrication cases, while 60 million won was fined to six local bioequivalence testing agencies.
The court ruled that these organizations partially made illegal conspiracies jointly over the test results.
Pharmaceutical business sources say...
The court ruled that these organizations partially made illegal conspiracies jointly over the test results.
Pharmaceutical business sources say...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.